Stereotactic Body Radiotherapy for Patients With Breast Cancer Oligometastasis

NCT03295916

EARLY_PHASE1INTERVENTIONAL

Juravinski Cancer Center

30 participants

Started 2018-01-01 · Completed 2021-04-01

Status: Unknown (as of 12-23-2025)

Conditions

Breast Cancer

Interventions

RADIATION: Stereotactic Body Radiotherapy

Linked Papers (from SciSciNet-V2)

Total Papers37

Background

6

Result

0

Derived

0

Unknown

31

View on ClinicalTrials.gov

Total Citations Per Year

Brief Summary

The purpose of this study is to evaluate feasibility to treat metachronous multi-site breast cancer oligometastasis with stereotactic body radiotherapy (SBRT) in patients on systemic therapy.

Sort by:

Background Papers12

Oligometastases and Oligo-recurrence: The New Era of Cancer Therapy

Oligometastases and Oligo-recurrence: The New Era of Cancer Therapy

Vertebral Compression Fracture After Spine Stereotactic Body Radiotherapy: A Multi-Institutional Analysis With a Focus on Radiation Dose and the Spinal Instability Neoplastic Score

Vertebral Compression Fracture After Spine Stereotactic Body Radiotherapy: A Multi-Institutional Analysis With a Focus on Radiation Dose and the Spinal Instability Neoplastic Score

Survival after hepatic resection of colorectal cancer metastases

Survival after hepatic resection of colorectal cancer metastases

Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data

Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data

Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54–56 Gy given in 9–7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size

Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54–56 Gy given in 9–7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size

Stereotactic body radiotherapy: a new paradigm in the management of spinal metastases

Stereotactic body radiotherapy: a new paradigm in the management of spinal metastases

Result Papers0

No result papers linked

Derived Papers0

No derived papers linked

Unknown Papers31

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

2,348 citations

Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases

1,483 citations

The stereotaxic method and radiosurgery of the brain.

1,397 citations

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

1,128 citations

Palliative Radiotherapy for Bone Metastases: An ASTRO Evidence-Based Guideline

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.

Stereotactic body radiotherapy for oligometastases

Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study

Phase II study on stereotactic body radiotherapy of colorectal metastases

Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment

Phase 3 Trials of Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for 1 to 4 Brain Metastases: Individual Patient Data Meta-Analysis

Surgical management and outcomes of colorectal cancer liver metastases

Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: A meta-analysis

Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis

Survival of metastatic breast carcinoma patients over a 20‐year period

AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breast Cancer

The Canadian Association of Radiation Oncology Scope of Practice Guidelines for Lung, Liver and Spine Stereotactic Body Radiotherapy

Stereotactic Radiotherapy for Pulmonary Oligometastases: A Systematic Review

Radiotherapy for Liver Metastases: A Review of Evidence

Local Surgical, Ablative, and Radiation Treatment of Metastases

Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy

Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy

DEGRO Practice Guidelines for Palliative Radiotherapy of Metastatic Breast Cancer

Combined‐modality treatment for isolated recurrences of breast carcinoma

Ten-year follow-up study of premenopausal women with metastatic breast cancer: an Eastern Cooperative Oncology Group study.

Management of Metastatic Bone Disease Algorithms for Diagnostics and Treatment.

DEGRO Practical Guidelines for Palliative Radiotherapy of Breast Cancer Patients: Brain Metastases and Leptomeningeal Carcinomatosis

Clinical prognostic factors and grading system for rib fracture following stereotactic body radiation therapy (SBRT) in patients with peripheral lung tumors

Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy

All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer